Skip to main navigation Skip to search Skip to main content

Erratum: Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice (PLoS Pathog (2020) 16:4 (e1008477) DOI: 10.1371/journal.ppat.1008477)

  • Nicole Caduff
  • , Donal McHugh
  • , Anita Murer
  • , Patrick Rämer
  • , Ana Raykova
  • , Vanessa Landtwing
  • , Lisa Rieble
  • , Christian W. Keller
  • , Michael Prummer
  • , Laurent Hoffmann
  • , Janice K.P. Lam
  • , Alan K.S. Chiang
  • , Friedrich Raulf
  • , Tarik Azzi
  • , Christoph Berger
  • , Tina Rubic-Schneider
  • , Elisabetta Traggiai
  • , Jan D. Lünemann
  • , Michael Kammüller
  • , Christian Münz

Research output: Contribution to journalComment/debate

1 Scopus citations

Abstract

The following information is missing from the Funding statement: AKSC was supported by a HMRF grant (18170462).

Original languageEnglish
JournalPLoS Pathogens
Volume16
Issue number12
DOIs
StatePublished - 21 Dec 2020
Externally publishedYes

Fingerprint

Dive into the research topics of 'Erratum: Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice (PLoS Pathog (2020) 16:4 (e1008477) DOI: 10.1371/journal.ppat.1008477)'. Together they form a unique fingerprint.

Cite this